Lifetech Scientific (SHENZHEN) Co., Ltd.
USPTO PatentsView assignee record - 103 granted patents across 18 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).
The verdict
According to USPTO PatentsView, Lifetech ranks #3,566 of 49,997 tracked US assignees by granted-patent volume, with 103 patents across 18 technology areas.
- #3,566
- of 49,997 US assignees by volume
- Top 21%
- by Innovation Score (46.3/100)
- 14.0
- avg claims per patent
- +267%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R3566 · Foreign Corporation #3,566 · 103 grants
GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL
- GRANTS-MID 103 grants
- TOP-DECILE #3,566/49,997
- PHOTO-FINISH Fastly
- CPC-FOCUS A61F · 18 areas
- INNOV-PAR 46.3/100
- CLAIMS-RICH 14.0 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-SURGE +267% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Fastly, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Lifetech’s 46.3 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Lifetech
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- AEye · near
AEye · near
46 score
- Gripple · near
Gripple · near
46 score
- Millennium Pharmaceu… · near
Millennium Pharmaceu… · near
46 score
- Lifetech Scientific… · this assignee
Lifetech Scientific… · this assignee
46 score
- Lygos · near
Lygos · near
46 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Lifetech's Innovation Score is 46.3/100 (top 21% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Lifetech?
Each dot is one of Lifetech’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Lifetech’s own 14.0 claims/patent is at or below the 17.5 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Lifetech's grants concentrate
Lifetech Scientific (SHENZHEN) Co., Ltd. is a focused PatentsView assignee: 18 CPC subclasses with 64.1% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2020 (22 grants) versus a trough of 2 in 2016. By volume, Lifetech sits between Fastly, Inc. and Nidec Copal Corporation.
Lifetech's three-year grant acceleration
From 2019–2021 to 2022–2024, Lifetech Scientific (SHENZHEN) Co., Ltd. moved from 42 to 43 grants (1.02x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #1,121. See the growth leaderboard.
Who files at Lifetech's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Fastly
Fastly, Inc.
103 patents
- Flatfrog Laborato…
FlatFrog Laboratories AB
103 patents
- In-situ
In-situ, Inc.
103 patents
- Industry-academic…
Industry-Academic Cooperation Foundation, Chosun University
103 patents
- MSA Technology
MSA Technology, LLC
103 patents
- Magnecomp
Magnecomp Corporation
103 patents
- Mazor Robotics
Mazor Robotics Ltd.
103 patents
- Nidec Copal
Nidec Copal Corporation
103 patents
- Lifetech Scientif… ◀
Lifetech Scientific (SHENZHEN) Co., Ltd.
103 patents
What this shows Lifetech holds 103 patents at rank #3,566, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Lifetech
By rank, the assignees closest to #3,566 in granted patent volume.
- Fastly, Inc. #3,562 · 103 patents
- FlatFrog Laboratories AB #3,563 · 103 patents
- In-situ, Inc. #3,564 · 103 patents
- Industry-Academic Cooperation Foundation, Chosun University #3,565 · 103 patents
- MSA Technology, LLC #3,567 · 103 patents
- Magnecomp Corporation #3,568 · 103 patents
- Mazor Robotics Ltd. #3,569 · 103 patents
- Nidec Copal Corporation #3,570 · 103 patents
Leaders in A61F (Filters Implantable Into Blood Vessels)
Other assignees with the most granted patents in Lifetech's primary technology class.
- The Procter & Gamble Company 1,426 in class
- Boston Scientific Scimed, Inc. 1,101 in class
- Edwards Lifesciences Corporation 1,101 in class
- DePuy Synthes Products, Inc. 851 in class
- Globus Medical, Inc. 752 in class
- Cook Medical Technologies LLC 700 in class
- Smith & Nephew, Inc. 541 in class
- Covidien LP 528 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Lifetech, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Lifetech ranks #89 of 3,082 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (46 here).
Similar claim depth
Nearest assignees by average claims per patent (14.0 here).
Lifetech's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
46 Top 21% higher than 79% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 2 | 1.9% |
| 2017 | 3 | 2.9% |
| 2018 | 8 | 7.8% |
| 2019 | 8 | 7.8% |
| 2020 | 22 | 21.4% |
| 2021 | 12 | 11.7% |
| 2022 | 13 | 12.6% |
| 2023 | 14 | 13.6% |
| 2024 | 16 | 15.5% |
| 2025partial year | 5 | 4.9% |
Which technologies does Lifetech Scientific (SHENZHEN) Co., Ltd. patent most?
Top 15 of 18 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Lifetech Scientific (SHENZHEN) Co., Ltd.'s patent record in context - here's where to go next.
- Lifetech Scientific (SHENZHEN) Co., Ltd.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 64.1% of its portfolio - see every assignee active in that class. Explore A61F
- Ranked #3,566 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Lifetech Scientific (SHENZHEN) Co., Ltd. against Fastly, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 46.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.